The agreement allows manufacturers to develop, manufacture and supply generic long-acting injectable cabotegravir for treatment in 133 countries.

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Market OutlineThe Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to ...

As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...